Accelerating NDA filing through faster carcinogenicity assessment
Drug Discovery World
MAY 10, 2023
This stage is more highly regulated and consists of both preclinical testing and clinical trials. Until recently, drug carcinogenicity assessment required two different in vivo studies, one of which was typically a two-year lifetime study in rats. Drug discovery and development is an arduous process that can cost upwards of $2.6
52 
Let's personalize your content